Prosecution Insights
Last updated: October 04, 2026

Temmerman Law

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

8 pending office actions • 3 clients • 7 examiners • 5 art units • 0 of 8 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Analysis

TEMMERMAN LAW focuses on Chemistry & Materials. The firm has a history of 613 career applications. Its resolved allowance rate is 84.05 percent. This percentage shows the proportion of resolved applications that successfully reach a grant. For a practitioner, this rate provides a benchmark for the firm's historical performance.

The firm currently manages 6 pending office actions. On average, the firm receives 3.1 office actions per allowance. This 3.1 office actions per allowance figure reflects the typical amount of negotiation with the USPTO. The 613 career applications and 6 pending office actions define the firm's historical and active workload. These data points characterize the firm's prosecution profile.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=613 apps, methodology: how we score firms)

84.0%
Allowance Rate
n=613
+0.61σ
Allowance Rate (norm)
n=613
3.1
OAs to Allowance
n=353
-0.29σ
OAs to Allow (norm)
n=353
912 days
Time to Allowance
n=353
+10.4pp
Interview Lift
n=613
23.3%
RCE Rate
n=613
2.7%
Appeal Rate
n=613

Rejection Performance (% of received rejections ultimately overcome)

78.1%
§101 Overcome
n=32
66.7%
§102 Overcome
n=120
73.3%
§103 Overcome
n=210
76.8%
§112 Overcome
n=194

Specialization & Scale

A61B, C12N, Y02E
Top CPC Subclasses
11%
Top-3 CPC Share
n=613
0
Practitioners
n=613
—
Apps / Practitioner
n=613 (min 20)

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (50%)
2
Medium (25%)
2
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (25%)
§112 only2 (25%)
Multi-statute (no §101)4 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHOSTAK, ANDREY 2 52.2% +61.8%
PARSLEY, DAVID J 1 54.0% +28.7%
KHAN, AMINA S 1 47.5% +43.0%
BEISNER, WILLIAM H 1 61.8% +29.1%
KRUER, KEVIN R 1 26.8% +29.4%
LEE, HOI YAN NMN 1 38.4% +75.9%
GALSTER, SAMUEL LEONARD 1 50.9% +43.2%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18614248 BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN SHOSTAK, ANDREY 27d
18205598 BLOOD HEALTH MONITORING METHOD AND DEVICE SHOSTAK, ANDREY 27d
18509620 DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIES BEISNER, WILLIAM H —
18241806 Durable Mycelium Bonding KRUER, KEVIN R —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17856527 ALGINATE, POLYLYSINE, AND SEED PRESERVATIVE NUTRITIONAL PRODUCT AND DIGESTIVE AID LEE, HOI YAN NMN 23d overdue
17856542 METHOD FOR NEUTRALIZING STOMACH ACID USING ALGINATE, POLYLYSINE, AND SEED PRESERVATIVES GALSTER, SAMUEL LEONARD 15d overdue
18614248 BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN SHOSTAK, ANDREY 27d
18205598 BLOOD HEALTH MONITORING METHOD AND DEVICE SHOSTAK, ANDREY 27d
19306889 MYCELIUM GROWTH BED WITH PERFORATION LAYER AND RELATED METHOD FOR CREATING A UNIFORM SHEET OF MYCELIUM FROM A SOLID-STATE MEDIUM PARSLEY, DAVID J —
18611594 Mycelial Leather Replacement Compositions with Improved Affinity to Anionic Aqueous Chemistry KHAN, AMINA S —
18509620 DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIES BEISNER, WILLIAM H —
18241806 Durable Mycelium Bonding KRUER, KEVIN R —

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
MycoWorks 4
SCOSCHE INDUSTRIES, INC. 2
REFLUX GOURMET LLC 2

Top Art Units

Art UnitApps
37912
16932
17611
17991
17871

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19306889 MYCELIUM GROWTH BED WITH PERFORATION LAYER AND RELATED METHOD FOR CREATING A UNIFORM SHEET OF MYCELIUM FROM A SOLID-STATE MEDIUM Mycoworks, Inc. PARSLEY, DAVID J §112 Non-Final OA — Pending Aug 21, 2025
18614248 BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN Scosche Industries, Inc. SHOSTAK, ANDREY 3791 §102§103§112 Non-Final OA 27d Pending Mar 22, 2024
18611594 Mycelial Leather Replacement Compositions with Improved Affinity to Anionic Aqueous Chemistry Mycoworks, Inc. KHAN, AMINA S 1761 §112 Non-Final OA — Pending Mar 20, 2024
18509620 DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIES Mycoworks, Inc. BEISNER, WILLIAM H 1799 §103§112 Non-Final OA — Pending Nov 15, 2023
18241806 Durable Mycelium Bonding Mycoworks, Inc. KRUER, KEVIN R 1787 §103§112 Non-Final OA — Pending Sep 01, 2023
18205598 BLOOD HEALTH MONITORING METHOD AND DEVICE Scosche Industries, Inc. SHOSTAK, ANDREY 3791 §102§103§112 Non-Final OA 27d Pending Jun 05, 2023
17856527 ALGINATE, POLYLYSINE, AND SEED PRESERVATIVE NUTRITIONAL PRODUCT AND DIGESTIVE AID Reflux Gourmet LLC LEE, HOI YAN NMN 1693 §103 Final Rejection 23d overdue Pending Jul 01, 2022
17856542 METHOD FOR NEUTRALIZING STOMACH ACID USING ALGINATE, POLYLYSINE, AND SEED PRESERVATIVES Reflux Gourmet LLC GALSTER, SAMUEL LEONARD 1693 §103 Final Rejection 15d overdue Pending Jul 01, 2022

Managing Temmerman Law's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month